Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Balance Sheet
Balance Sheet Decomposition
Arcturus Therapeutics Holdings Inc
Current Assets | 386.6m |
Cash & Short-Term Investments | 292m |
Receivables | 32.1m |
Other Current Assets | 62.5m |
Non-Current Assets | 42.8m |
PP&E | 40.9m |
Other Non-Current Assets | 1.9m |
Current Liabilities | 82m |
Accounts Payable | 5.3m |
Accrued Liabilities | 31.9m |
Other Current Liabilities | 44.8m |
Non-Current Liabilities | 68.9m |
Other Non-Current Liabilities | 68.9m |
Balance Sheet
Arcturus Therapeutics Holdings Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
2
|
17
|
8
|
25
|
37
|
71
|
463
|
371
|
392
|
292
|
|
Cash Equivalents |
2
|
17
|
8
|
25
|
37
|
71
|
463
|
371
|
392
|
292
|
|
Short-Term Investments |
20
|
34
|
0
|
24
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
0
|
0
|
4
|
1
|
5
|
2
|
2
|
3
|
3
|
32
|
|
Accounts Receivables |
0
|
0
|
4
|
1
|
5
|
2
|
2
|
3
|
3
|
32
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
0
|
2
|
0
|
2
|
1
|
1
|
3
|
5
|
9
|
63
|
|
Total Current Assets |
22
|
52
|
12
|
51
|
42
|
74
|
468
|
379
|
403
|
387
|
|
PP&E Net |
0
|
0
|
1
|
1
|
2
|
8
|
9
|
11
|
45
|
41
|
|
PP&E Gross |
0
|
0
|
1
|
1
|
0
|
8
|
9
|
11
|
45
|
41
|
|
Accumulated Depreciation |
0
|
0
|
1
|
1
|
0
|
2
|
3
|
4
|
6
|
9
|
|
Long-Term Investments |
0
|
19
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
Total Assets |
22
N/A
|
72
+222%
|
14
-81%
|
52
+280%
|
44
-15%
|
82
+86%
|
477
+480%
|
393
-18%
|
450
+15%
|
429
-5%
|
|
Liabilities | |||||||||||
Accounts Payable |
0
|
0
|
3
|
2
|
2
|
6
|
11
|
10
|
7
|
5
|
|
Accrued Liabilities |
2
|
2
|
0
|
2
|
4
|
4
|
19
|
24
|
30
|
32
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
23
|
61
|
0
|
|
Other Current Liabilities |
0
|
0
|
5
|
7
|
6
|
11
|
18
|
44
|
29
|
45
|
|
Total Current Liabilities |
2
|
2
|
9
|
11
|
13
|
21
|
50
|
100
|
127
|
82
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
10
|
15
|
14
|
41
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
3
|
7
|
8
|
20
|
17
|
24
|
53
|
69
|
|
Total Liabilities |
2
N/A
|
2
N/A
|
12
+408%
|
18
+49%
|
31
+68%
|
56
+84%
|
80
+42%
|
165
+106%
|
180
+9%
|
151
-16%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
52
|
71
|
12
|
23
|
45
|
72
|
144
|
348
|
338
|
368
|
|
Additional Paid In Capital |
72
|
140
|
14
|
57
|
58
|
97
|
540
|
576
|
608
|
646
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
20
N/A
|
69
+248%
|
2
-98%
|
34
+2 013%
|
14
-60%
|
26
+90%
|
397
+1 437%
|
228
-42%
|
270
+18%
|
279
+3%
|
|
Total Liabilities & Equity |
22
N/A
|
72
+222%
|
14
-81%
|
52
+280%
|
44
-15%
|
82
+86%
|
477
+480%
|
393
-18%
|
450
+15%
|
429
-5%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
2
|
4
|
3
|
11
|
11
|
15
|
26
|
26
|
27
|
27
|